CLOs on the Move

Erchonia Medical

www.erchonia.com

 
Erchonia Medical is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Mckinney, TX. To find more information about Erchonia Medical, please visit www.erchonia.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.erchonia.com
  • 2021 Commerce Dr
    Mckinney, TX USA 75069-8262
  • Phone: 214.544.2227

Executives

Name Title Contact Details

Similar Companies

The Evaluation Group

The Evaluation Group is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

StoneRidge Treatment & Recovery

StoneRidge Treatment & Recovery is a leading addiction treatment center located in Prescott Valley. We specialize in providing world-class brain-focused mental health and addiction services. Our comprehensive approach includes addiction detox services,...

Danaher

Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.

Ramp Health

Ramp Health is a company that provides comprehensive healthcare and safety services to employer, health plan, and government clients.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.